Vascular benefits of angiotensin receptor blockers

Author： Voors   Adriaan A  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.7, 2007-06, pp. : 987-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular and metabolic effects of angiotensin II receptor blockers

By Barra Silvia   Vitagliano Alice   Cuomo Vittoria   Vitagliano Giancarlo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 173-189

Informa Healthcare

Access to resources Recommend Favorite

Drug interactions with angiotensin receptor blockers

By Böhler Steffen   Pittrow David   Bramlage Peter   Kirch Wilhelm  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 7-18

Informa Healthcare

Access to resources Recommend Favorite

Economic Benefits of Treating High-Risk Hypertension with Angiotensin II Receptor Antagonists (Blockers)

By Coca Antonio  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 211-220

Adis International

Access to resources Recommend Favorite

Efficacy of Angiotensin Receptor Blockers in Cardiovascular Disease

By Maggioni Aldo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 4, 2006-08 ,pp. : 295-308

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin Receptor Blockers and the Risk of Malignancy: A Note of Caution

By Sica Domenic A.  

Drug Safety, Vol. 33, Iss. 9, 2010-09 ,pp. : 709-712

Adis International

Access to resources Recommend Favorite